These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 23227125)
1. Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization. Nie Y; Ji L; Ding H; Xie L; Li L; He B; Wu Y; Gu Z Theranostics; 2012; 2(11):1092-103. PubMed ID: 23227125 [TBL] [Abstract][Full Text] [Related]
3. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361 [TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery. Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909 [TBL] [Abstract][Full Text] [Related]
5. Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina. Geng S; Yang B; Wang G; Qin G; Wada S; Wang JY Nanotechnology; 2014 Jul; 25(27):275103. PubMed ID: 24960297 [TBL] [Abstract][Full Text] [Related]
7. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes. Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158 [TBL] [Abstract][Full Text] [Related]
8. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect. Ahmed KS; Shan X; Mao J; Qiu L; Chen J Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679 [TBL] [Abstract][Full Text] [Related]
9. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity. Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094 [TBL] [Abstract][Full Text] [Related]
10. Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery. Tang J; Fu H; Kuang Q; Zhang L; Zhang Q; Liu Y; Ran R; Gao H; Zhang Z; He Q J Drug Target; 2014 May; 22(4):313-26. PubMed ID: 24404866 [TBL] [Abstract][Full Text] [Related]
11. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma. Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882 [TBL] [Abstract][Full Text] [Related]
12. Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma. Wei M; Guo X; Tu L; Zou Q; Li Q; Tang C; Chen B; Xu Y; Wu C Int J Nanomedicine; 2015; 10():5123-37. PubMed ID: 26316745 [TBL] [Abstract][Full Text] [Related]
13. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. Moosavian SA; Abnous K; Badiee A; Jaafari MR Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819 [TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs. Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779 [TBL] [Abstract][Full Text] [Related]
15. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior. Li Y; Liu R; Yang J; Shi Y; Ma G; Zhang Z; Zhang X Biomaterials; 2015 Feb; 41():1-14. PubMed ID: 25522960 [TBL] [Abstract][Full Text] [Related]
16. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation. Pathak P; Dhawan V; Magarkar A; Danne R; Govindarajan S; Ghosh S; Steiniger F; Chaudhari P; Gopal V; Bunker A; Róg T; Fahr A; Nagarsenker M Int J Pharm; 2016 Jul; 509(1-2):149-158. PubMed ID: 27231122 [TBL] [Abstract][Full Text] [Related]
17. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity. Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937 [TBL] [Abstract][Full Text] [Related]
18. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160 [TBL] [Abstract][Full Text] [Related]
19. Physical stability of cholesterol derivatives combined with liposomes and their in vitro behavior. Yang B; Geng SY; Wang JY Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():4114-7. PubMed ID: 24110637 [TBL] [Abstract][Full Text] [Related]
20. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models. Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]